These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 29216020)

  • 1. Hydrolyzed Formula With Reduced Protein Content Supports Adequate Growth: A Randomized Controlled Noninferiority Trial.
    Ahrens B; Hellmuth C; Haiden N; Olbertz D; Hamelmann E; Vusurovic M; Fleddermann M; Roehle R; Knoll A; Koletzko B; Wahn U; Beyer K
    J Pediatr Gastroenterol Nutr; 2018 May; 66(5):822-830. PubMed ID: 29216020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Short- and long-term effects of feeding hydrolyzed protein infant formulas on growth at < or = 6 y of age: results from the German Infant Nutritional Intervention Study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2009 Jun; 89(6):1846-56. PubMed ID: 19369380
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth and tolerance of healthy, term infants fed lower protein extensively hydrolyzed or amino acid-based formula: double-blind, randomized, controlled trial.
    Adams CB; Johnston WH; Deulofeut H; Leader J; Rhodes R; Yeiser M; Harris CL; Wampler JL; Hill RJ; Cooper T
    BMC Pediatr; 2021 Jul; 21(1):323. PubMed ID: 34289820
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adequacy and safety of an infant formula with a protein/energy ratio of 1.8 g/100 kcal and enhanced protein efficiency for term infants during the first 4 months of life.
    Turck D; Grillon C; Lachambre E; Robiliard P; Beck L; Maurin JL; Kempf C; Bernet JP; Marx J; Lebrun F; Van Egroo LD
    J Pediatr Gastroenterol Nutr; 2006 Sep; 43(3):364-71. PubMed ID: 16954961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term effects of hydrolyzed protein infant formulas on growth--extended follow-up to 10 y of age: results from the German Infant Nutritional Intervention (GINI) study.
    Rzehak P; Sausenthaler S; Koletzko S; Reinhardt D; von Berg A; Krämer U; Berdel D; Bollrath C; Grübl A; Bauer CP; Wichmann HE; Heinrich J;
    Am J Clin Nutr; 2011 Dec; 94(6 Suppl):1803S-1807S. PubMed ID: 21849601
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An Infant Formula with Partially Hydrolyzed Whey Protein Supports Adequate Growth and Is Safe and Well-Tolerated in Healthy, Term Infants: A Randomized, Double-Blind, Equivalence Trial.
    Picaud JC; Pajek B; Arciszewska M; Tarczón I; Escribano J; Porcel R; Adelt T; Hassink E; Rijnierse A; Abrahamse-Berkeveld M; Korczowski B; On Behalf Of The Tenuto Study Group
    Nutrients; 2020 Jul; 12(7):. PubMed ID: 32668666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Growth of healthy term infants fed partially hydrolyzed whey-based infant formula: a randomized, blinded, controlled trial.
    Borschel MW; Choe YS; Kajzer JA
    Clin Pediatr (Phila); 2014 Dec; 53(14):1375-82. PubMed ID: 25009115
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of Growth of Healthy Term Infants Fed Extensively Hydrolyzed Protein- and Amino Acid-Based Infant Formulas.
    Borschel MW; Baggs GE; Oliver JS
    Nutrients; 2018 Mar; 10(3):. PubMed ID: 29494498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Partially Hydrolyzed Whey Infant Formula Supports Appropriate Growth: A Randomized Controlled Non-Inferiority Trial.
    Karaglani E; Thijs-Verhoeven I; Gros M; Chairistanidou C; Zervas G; Filoilia C; Kampani TM; Miligkos V; Matiatou M; Valaveri S; Sakellariou A; Babilis G; Bos R; Manios Y
    Nutrients; 2020 Oct; 12(10):. PubMed ID: 33036201
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Programming: Effects of Early Nutrition on Growth, Metabolism and Body Composition.
    Haschke F; Grathwohl D; Haiden N
    Nestle Nutr Inst Workshop Ser; 2016; 86():87-95. PubMed ID: 27337043
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synbiotics-supplemented amino acid-based formula supports adequate growth in cow's milk allergic infants.
    Burks AW; Harthoorn LF; Van Ampting MT; Oude Nijhuis MM; Langford JE; Wopereis H; Goldberg SB; Ong PY; Essink BJ; Scott RB; Harvey BM
    Pediatr Allergy Immunol; 2015 Jun; 26(4):316-22. PubMed ID: 25845680
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Type of infant formula increases early weight gain and impacts energy balance: a randomized controlled trial.
    Mennella JA; Inamdar L; Pressman N; Schall JI; Papas MA; Schoeller D; Stallings VA; Trabulsi JC
    Am J Clin Nutr; 2018 Nov; 108(5):1015-1025. PubMed ID: 30295700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth and safety evaluation of infant formulae containing oligosaccharides derived from bovine milk: a randomized, double-blind, noninferiority trial.
    Meli F; Puccio G; Cajozzo C; Ricottone GL; Pecquet S; Sprenger N; Steenhout P
    BMC Pediatr; 2014 Dec; 14():306. PubMed ID: 25527244
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infant formula composition affects energetic efficiency for growth: the BeMIM study, a randomized controlled trial.
    Fleddermann M; Demmelmair H; Grote V; Nikolic T; Trisic B; Koletzko B
    Clin Nutr; 2014 Aug; 33(4):588-95. PubMed ID: 24411489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Partially Hydrolysed Whey-Based Formulae with Reduced Protein Content Support Adequate Infant Growth and Are Well Tolerated: Results of a Randomised Controlled Trial in Healthy Term Infants.
    Rigo J; Schoen S; Verghote M; van Overmeire B; Marion W; Abrahamse-Berkeveld M; Alliet P
    Nutrients; 2019 Jul; 11(7):. PubMed ID: 31331065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth of infants fed formula rich in canola oil (low erucic acid rapeseed oil).
    Rzehak P; Koletzko S; Koletzko B; Sausenthaler S; Reinhardt D; Grübl A; Bauer CP; Krämer U; Bollrath C; von Berg A; Berdel D; Wichmann HE; Heinrich J;
    Clin Nutr; 2011 Jun; 30(3):339-45. PubMed ID: 21130544
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Growth and tolerance of formula with lactoferrin in infants through one year of age: double-blind, randomized, controlled trial.
    Johnston WH; Ashley C; Yeiser M; Harris CL; Stolz SI; Wampler JL; Wittke A; Cooper TR
    BMC Pediatr; 2015 Nov; 15():173. PubMed ID: 26547414
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stool microbiome, pH and short/branched chain fatty acids in infants receiving extensively hydrolyzed formula, amino acid formula, or human milk through two months of age.
    Kok CR; Brabec B; Chichlowski M; Harris CL; Moore N; Wampler JL; Vanderhoof J; Rose D; Hutkins R
    BMC Microbiol; 2020 Nov; 20(1):337. PubMed ID: 33167908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A modified low-protein infant formula supports adequate growth in healthy, term infants: a randomized, double-blind, equivalence trial.
    Kouwenhoven SMP; Antl N; Finken MJJ; Twisk JWR; van der Beek EM; Abrahamse-Berkeveld M; van de Heijning BJM; Schierbeek H; Holdt LM; van Goudoever JB; Koletzko BV
    Am J Clin Nutr; 2020 May; 111(5):962-974. PubMed ID: 31868201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and Suitability of an Infant Formula Manufactured from Extensively Hydrolysed Protein in Healthy Term Infants.
    Otten L; Schelker E; Petersen H; Nomayo A; Fleddermann M; Arendt BM; Britzl T; Haberl EM; Jochum F;
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111119
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.